EXODIAB: Excellence of Diabetes Research in Sweden
941 – 950 of 4131
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Atherosclerosis : cell biology and lipoproteins
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Serum aromatic and branched-chain amino acids associated with NASH demonstrate divergent associations with serum lipids
(
- Contribution to journal › Article
-
Mark
Paracetamol analogues conjugated by FAAH induce TRPV1-mediated antinociception without causing acute liver toxicity
(
- Contribution to journal › Article
-
Mark
Assessment of lifestyle factors helps to identify liver fibrosis due to non-alcoholic fatty liver disease in obesity
(
- Contribution to journal › Article
-
Mark
The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients
(
- Contribution to journal › Article
-
Mark
Detecting COVID-19 infection hotspots in England using large-scale self-reported data from a mobile application : a prospective, observational study
(
- Contribution to journal › Article
-
Mark
Genome-Wide Association Analysis of Pancreatic Beta-Cell Glucose Sensitivity
(
- Contribution to journal › Article
-
Mark
Plasma Vitamin C and type 2 diabetes : Genome-wide association study and mendelian randomization analysis in European populations
(
- Contribution to journal › Article
-
Mark
Adherence to oral glucose tolerance testing in children in stage 1 of type 1 diabetes : The TEDDY study
(
- Contribution to journal › Article
-
Mark
A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol
(
- Contribution to journal › Article